| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sorrento Therapeutics, Inc. (SRNE) has 0 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. SRNE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2017 | Shah Jaisim | Director | Buy | 10,002 | $1.79 | $17,903.58 | +9.7% | |
| Apr 19, 2017 | Ji Henry | President And CEO | Buy | 100,000 | $2.00 | $200,000.00 | +251.4% | |
| Apr 19, 2017 | Abg Management Ltd | 10% Owner | Buy | 550,000 | $2.00 | $1,100,000.00 | +38.2% | |
| Apr 13, 2017 | Abg Management Ltd | 10% Owner | Buy | 2,500,000 | $2.00 | $5,000,000.00 | +628.4% | |
| Feb 22, 2017 | Ji Henry | President And CEO | Buy | 2,000 | $5.60 | $11,200.00 | +5.3% | |
| Feb 3, 2017 | Ng George K | See Remarks | Sell | 40,000 | $5.15 | $206,000.00 | -44.8% | |
| Feb 3, 2017 | Su Jeffrey | Executive VP And COO | Buy | 4,000 | $5.15 | $20,600.00 | +44.4% | |
| Feb 3, 2017 | Herde Kevin | Executive VP And CFO | Buy | 3,000 | $5.15 | $15,450.00 | +75.0% | |
| Feb 3, 2017 | Ji Henry | President And CEO | Buy | 20,000 | $5.15 | $103,000.00 | +112.5% | |
| Feb 3, 2017 | Zeldis Jerome B45 | See Remarks | Buy | 10,000 | $5.15 | $51,500.00 | New |